Lv3
350 积分 2023-07-08 加入
Reply to: Type 2 inflammatory biomarkers in asthma and COPD: what we think we know
4个月前
已完结
Phenotyping the responses to systemic corticosteroids in the management of asthma attacks (PRISMA)
4个月前
已完结
Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis
4个月前
已完结
Long-term efficacy but rare sustained remission: Individual-level five-year stability in anti-IL5/Rα biologic therapy response for severe asthma
5个月前
已关闭
Long-term efficacy but rare sustained remission: Individual-level five-year stability in anti-IL5/Rα biologic therapy response for severe asthma
5个月前
已关闭
Patient Factors and Clinical Efficacy of Early Identification and Treatment of COPD and Asthma
5个月前
已完结
GPR43 in eosinophils suppresses the emergence of pathogenic Siglec-Fhi neutrophils in allergic airway inflammation in mice
5个月前
已关闭
[Detection of small airway dysfunction in bronchial asthma and its clinical application]
6个月前
已完结
Effect of obesity on airway and systemic inflammation in adults with asthma: a systematic review and meta-analysis
6个月前
已完结
Obesity-related Asthma: A Pathobiology-based Overview of Existing and Emerging Treatment Approaches
7个月前
已完结
皖公网安备34019202002308
